Global /United Kingdom /Healthcare /Drug Manufacturers - Specialty & Generic /ANCR

Animalcare Group plc

ANCR

• LSE: ANCR • Delayed

333GBX -0.9%

4.44 USD

As of 7 June 2026, Animalcare Group plc has a market cap of $308.67M USD, ranking #18430 globally and #424 in the United Kingdom. It ranks #1673 in the Healthcare sector, and #92 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

18430

Country Rank

424

Sector Rank

1673

Industry Rank

Key Stats

Market Cap

$308.67MUSD

229.92M GBP

Enterprise Value

$321.46MUSD

241.03M GBP

Revenue (TTM)

$108.84MUSD

81.07M GBP

EBITDA (TTM)

$9.64MUSD

7.23M GBP

Net Income (TTM)

$4.0MUSD

2.98M GBP

EBITDA Margin

8.9%

Profit Margin

3.7%

PE Ratio

73.8

Forward PE

22.4

PS Ratio

2.8

PB Ratio

2.0

EV/EBITDA

29.2

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Jennifer Ann Winter open_in_new

Employees

201

Website

animalcaregroup.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.9%	35%	23%	31%	44%	41%	51%	67%	27%

News

Markets

Exchange	Ticker	Price	Quotes
London Stock Exchange (LSE / LON) MIC: XLON PRIMARY	ANCR Animalcare Group PLC ISIN: GB0032350695 Shares Out.: Shares Outstanding: 69.046M¹ Shares Float: 50.866M² TV: TradingView: LSE: ANCR SA: Stock Analysis: LON: ANCR YF: Yahoo Finance: ANCR.L GF: Google Finance: LON: ANCR BA: Barron's: ANCR MS: Morningstar: XLON: ANCR	333 GBX	TV: TradingView: LSE: ANCR SA: Stock Analysis: LON: ANCR YF: Yahoo Finance: ANCR.L GF: Google Finance: LON: ANCR BA: Barron's: ANCR MS: Morningstar: XLON: ANCR

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Animalcare Group plc

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, the United Kingdom.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
Hikma Pharmaceuticals PLC LSE: HIK	$4.01B 2.98B GBP 1K%	10.3	United Kingdom
Allergy Therapeutics plc LSE: AGY	$875.65M 652.25M GBP 184%	-	United Kingdom
Applied Nutrition Plc LSE: APN	$721.59M 537.5M GBP 134%	19.5	United Kingdom
ImmuPharma plc LSE: IMM	$35.18M 26.2M GBP -89%	-	United Kingdom
Provexis plc LSE: PXS	$32.28M 24.05M GBP -90%	-	United Kingdom
Celadon Pharmaceuticals Plc LSE: CEL	$12.38M 9.23M GBP -96%	-	United Kingdom

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 12K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 9K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 5K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 4K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 3K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 3K%	80.6	China

chevron_leftBack